Consequently, suppressing autophagy or PIK3C3 or ATG12 expression can effectively hinder the influential impact of SH3BGRL on doxorubicin resistance in BC cells, both in laboratory settings and in living organisms. This evidence concerns the gene SH3BGRL and breast cancer.